Clinical trials
Completed Phase 3 trials in Indonesia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
137 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 9 |
| 2007 | 12 |
| 2008 | 4 |
| 2009 | 10 |
| 2010 | 3 |
| 2011 | 11 |
| 2012 | 10 |
| 2013 | 8 |
| 2014 | 1 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 137 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Indonesia University | 15 |
| Bayer | 10 |
| Dexa Medica Group | 9 |
| AstraZeneca | 8 |
| PT Bio Farma | 7 |
| Bristol-Myers Squibb | 6 |
| Hoffmann-La Roche | 6 |
| Innogene Kalbiotech Pte. Ltd | 3 |
| National Cardiovascular Center Harapan Kita Hospital Indonesia | 3 |
| Novartis Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 7 |
| COVID-19 | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Tuberculosis | 4 |
| Venous Thromboembolism | 4 |
| Cardiac Output, Low | 3 |
| Cardiovascular Diseases | 3 |
| Heart Defects, Congenital | 3 |
| Malaria, Vivax | 3 |
| Neoplasm Metastasis | 3 |
Trials
Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.
37 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.